As international COVID-19 vaccination rates remain slow, some public health officials are worried more contagious variants are proliferating quickly enough that herd immunity won’t reduce the risk they pose.
BioNTech said it “has developed a comprehensive strategy to address these variants should the need arise in the future.” For example, the FDA has approved plans made by BioNTech and Pfizer to study the effectiveness of a third vaccine dose for prolonged immunity and protection against variants.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
